CarolynNancyKrasnerMD

PubMed

• Combined aromatase, CDK4/6 and PI3K blockade using letrozole/abemaciclib/LY3023414 in endometrial cancer.
  Xiong, N., Sawyer, H., Polak, M., Needham, H., Geddes, M., Koppermann, L., Shea, M., Castro, C., Cheng, S., Konstantinopoulos, P., Krasner, C., Liu, J., Matulonis, U.,...> ;Gynecologic Oncology Reports. 2024 Apr 1
• 2 citations
  Kidney function in patients with ovarian cancer treated with poly (ADP-ribose) polymerase (PARP) inhibitors.
  Shruti Gupta, Paul E Hanna, Tianqi Ouyang, Karla Sofia Yamada, Rani Sawtell, Qiyu Wang, Nurit Katz-Agranov, Lea Feghali, Carolyn N Krasner, Sara Bouberhan, Cesar M Cas...> ;Journal of the National Cancer Institute. 2023 Jul 6
• 1 citations
  Phase II Trials of Iniparib (BSI-201) in Combination with Gemcitabine and Carboplatin in Patients with Recurrent Ovarian Cancer.
  Richard T Penson, Allison J Ambrosio, Christin A Whalen, Carolyn N Krasner, Panagiotis A Konstantinopoulos, Charles Bradley, Ursula A Matulonis, Michael J Birrer> ;The Oncologist. 2023 Mar 17
• 17 citations
  A Phase II, Two-Stage Study of Letrozole and Abemaciclib in Estrogen Receptor-Positive Recurrent Endometrial Cancer.
  Kolin, D., Kolin, D., Panagiotis A Konstantinopoulos, Elizabeth K Lee, Niya Xiong, Carolyn Krasner, Susana Campos, David L Kolin, Joyce F Liu, Neil Horowitz, Alexi A W...> ;Journal of Clinical Oncology. 2023 Jan 20
• A randomized phase II trial of bevacizumab vs. bevacizumab and erlotinib as first-line consolidation after carboplatin, paclitaxel, and bevacizumab in newly diagnosed ...
  Susana Campos, Ursula Matulonis, Suzanne Berlin, Neil Horowitz, Joyce Liu, Carolyn Krasner, Lee Hang, Corrine Zarwan, William Barry, Tina Colella, Christen Whalen, Mel...> ;International Journal of Clinical Oncology. 2022 Dec 1
• 12 citations
  Evaluation of Treatment With Talazoparib and Avelumab in Patients With Recurrent Mismatch Repair Proficient Endometrial Cancer.
  Panagiotis A Konstantinopoulos, Allison A Gockley, Niya Xiong, Carolyn Krasner, Neil Horowitz, Susana Campos, Alexi A Wright, Joyce F Liu, Meghan Shea, Oladapo Yeku, C...> ;JAMA Oncology. 2022 Sep 1
• 1 citations
  A phase I study of AZD2171 and Temsirolimus in patients with advanced gynecological malignancies.
  Susana M Campos, Suzanne Berlin, Carolyn N Krasner, Christin Whalen, Tina Atkinson, Kristin Meegan, Lauren Pereira, Karin Tyburski, Weixiu Lou, Hang Lee, Neil Horowitz...> ;Cancer Chemotherapy and Pharmacology. 2022 Mar 1
• 13 citations
  Sequential Phase II clinical trials evaluating CRLX101 as monotherapy and in combination with bevacizumab in recurrent ovarian cancer.
  Carolyn N. Krasner, Susana M. Campos, Chantay L. Young, Karan R. Chadda, Hang Lee, Michael J. Birrer, Neil S. Horowitz, Panagiotis A. Konstantinopoulos, Antonella M. D...> ;Gynecologic Oncology. 2021 Sep 1
• 71 citations
  Phase II Study of the WEE1 Inhibitor Adavosertib in Recurrent Uterine Serous Carcinoma.
  Joyce F. Liu, Niya Xiong, Susana M. Campos, Alexi A. Wright, Carolyn N. Krasner, Susan Schumer, Neil S. Horowitz, Jennifer Taylor Veneris, Nabihah Tayob, Stephanie Mor...> ;Journal of Clinical Oncology. 2021 Mar 11
• 5 citations
  Stepping into survivorship pilot study: Harnessing mobile health and principles of behavioral economics to increase physical activity in ovarian cancer survivors.
  Elizabeth Schrier, Niya Xiong, Embree Thompson, Hanneke Poort, Susan Schumer, Joyce F. Liu, Carolyn N. Krasner, Susana M. Campos, Neil S. Horowitz, Colleen M. Feltmate...> ;Gynecologic Oncology. 2021 Feb 23
• 10 citations
  A phase Ib/II and pharmacokinetic study of EP0057 (formerly CRLX101) in combination with weekly paclitaxel in patients with recurrent or persistent epithelial ovarian,...
  Linda R. Duska, Carolyn N. Krasner, David M. O'Malley, John L. Hays, Susan C. Modesitt, Cara Mathews, Kathleen N. Moore, Premal H. Thaker, Anthony B. Miller, Christoph...> ;Gynecologic Oncology. 2021 Mar 1
• 36 citations
  Combined pembrolizumab and pegylated liposomal doxorubicin in platinum resistant ovarian cancer: A phase 2 clinical trial.
  Elizabeth K. Lee, Niya Xiong, Su-Chun Cheng, William T. Barry, Richard T. Penson, Panagiotis A. Konstantinopoulos, Mark A. Hoffman, Neil S. Horowitz, Don S. Dizon, Eli...> ;Gynecologic Oncology. 2020 Aug 6
• 125 citations
  Phase II Study of Avelumab in Patients With Mismatch Repair Deficient and Mismatch Repair Proficient Recurrent/Persistent Endometrial Cancer.
  Panagiotis A. Konstantinopoulos, Weixiu Luo, Joyce F. Liu, Doga Gulhan, Carolyn N. Krasner, Jeffrey J. Ishizuka, Allison Gockley, Mary K. Buss, Whitfield B. Growdon, H...> ;Journal of Clinical Oncology. 2019 Aug 28
• 3 citations
  Final report on serial phase II trials of all-intraperitoneal chemotherapy with or without bevacizumab for women with newly diagnosed, optimally cytoreduced carcinoma ...
  Carolyn N. Krasner, Cesar M. Castro, Richard T. Penson, Maria Roche, Ursula A. Matulonis, Mark A. Morgan, Charles W. Drescher, D. K. Armstrong, J.K. Wolfe, Hang Lee, J...> ;Gynecologic Oncology. 2019 May 1
• A tumor board report of an 83-year-old woman with stage IB grade 3 endometrioid endometrial adenocarcinoma.
  Stephanie Alimena, Steven Fiascone, Carolyn N. Krasner, Martin T. King, Neil S. Horowitz> ;Current Problems in Cancer. 2019 Feb 7
• 1 citations
  Phase 1 and 2 study of carboplatin and pralatrexate in patients with recurrent, platinum-sensitive ovarian, fallopian tube, or primary peritoneal cancer.
  Marcela G. del Carmen, Jeffrey G. Supko, Nora Horick, J. Alejandro Rauh-Hain, Rachel M. Clark, Susana M. Campos, Carolyn N. Krasner, T. Atkinson, Michael J. Birrer> ;Cancer. 2016 Nov 1
• 11 citations
  Extended carboplatin infusion does not reduce frequency of hypersensitivity reaction at initiation of retreatment in patients with recurrent platinum-sensitive ovarian...
  Timothy Lax, Don S. Dizon, Michael J. Birrer, Aidan A. Long, Marcela G. del Carmen, Annekathryn Goodman, Carolyn N. Krasner, Richard T. Penson, Whitfield B. Growdon, C...> ;The Journal of Allergy and Clinical Immunology. in Practice. 2017 Jan 1
• 6 citations
  A SNaPshot of potentially personalized care: Molecular diagnostics in gynecologic cancer.
  Richard T. Penson, E. Sales, L. Sullivan, Darrell R. Borger, Carolyn N. Krasner, Annekathryn Goodman, M.G. del Carmen, Whitfield B. Growdon, John O. Schorge, David M. ...> ;Gynecologic Oncology. 2016 Apr 1
• 39 citations
  Phase I study of combination of vorinostat, carboplatin, and gemcitabine in women with recurrent, platinum-sensitive epithelial ovarian, fallopian tube, or peritoneal ...
  Ursula A. Matulonis, Suzanne Berlin, Hang Lee, Christin Whalen, Elizabeth Obermayer, Richard T. Penson, Joyce F. Liu, Susana M. Campos, Carolyn N. Krasner, Neil S. Hor...> ;Cancer Chemotherapy and Pharmacology. 2015 Jun 29
• 64 citations
  Translational Impact of Nanoparticle–Drug Conjugate CRLX101 with or without Bevacizumab in Advanced Ovarian Cancer
  Elizabeth Pham, Michael J. Birrer, Scott Eliasof, Edward Graeme Garmey, Douglas Lazarus, Christina R. Lee, Shan Man, Ursula A. Matulonis, Christian G. Peters, Ping Xu,...> ;Clinical Cancer Research. 2015 Feb 15
• 29 citations
  Catumaxomab for the treatment of malignant ascites in patients with chemotherapy-refractory ovarian cancer a phase II study
  Jonathan S. Berek, Robert P. Edwards, Lynn P. Parker, Leslie R. DeMars, Thomas J. Herzog, Samuel S. Lentz, Robert T. Morris, Wallace Akerley, Robert W. Holloway, Micha...> ;International Journal of Gynecological Cancer. 2014 Nov 1
• 62 citations
  Phase 2 trial of aromatase inhibition with letrozole in patients with uterine leiomyosarcomas expressing estrogen and/or progesterone receptors
  Suzanne George, Yang Feng, Judith Manola, Marisa R. Nucci, James E. Butrynski, Jeffrey A. Morgan, Nikhil H. Ramaiya, Richard Quek, Richard T. Penson, Andrew J. Wagner,...> ;Cancer. 2014 Mar 1
• 13 citations
  Patterns of recurrence in patients treated with bevacizumab in the primary treatment of advanced epithelial ovarian cancer.
  Jose Alejandro Rauh-Hain, Stephanie H. Guseh, Katharine M. Esselen, Whitfield B. Growdon, John O. Schorge, Neil S. Horowitz, Carolyn N. Krasner, Marcela G. del Carmen,...> ;International Journal of Gynecological Cancer. 2013 Sep 1
• 10 citations
  Phase II study of weekly PM00104 (ZALYPSIS(®)) in patients with pretreated advanced/metastatic endometrial or cervical cancer.
  Lainie P. Martin, Carolyn N. Krasner, Teresa Rutledge, Manuel Luque Ibañes, Eva M. Fernández-García, Carmen Kahatt, Mariano Siguero Gómez, Scott McMeekin> ;Medical Oncology. 2013 Jun 15
• 23 citations
  Trabectedin as single agent in relapsed advanced ovarian cancer: results from a retrospective pooled analysis of three phase II trials
  Jose Maria Del Campo, Cristiana Sessa, Carolyn N. Krasner, Jan B. Vermorken, Nicoletta Colombo, Stan B. Kaye, Martin Gore, P. Zintl, J. Gomez, Trilok V. Parekh, Youn C...> ;Medical Oncology. 2013 Feb 9
• Join now to see all